Ashvattha Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel hydroxyl dendrimer (HD) therapeutics (HDTs) to treat unmet medical needs in oncology, ophthalmology, and inflammatory diseases.

Biotechnology

Ashvattha Therapeutics

Jeffrey L. Cleland

Christine S.

Steve Maricich

Mark Feng

Jennifer Herber

Jay Z.

Debra Nguyen

Jeannie Skinner

Elizabeth Torrelio

Natacha Le Moan

Jiazhong Zhang

Steve Carlos

The Scientific Advisory Team at Ashvattha Therapeutics provides expert guidance and consultation on the development and clinical strategy of hydroxyl dendrimer therapeutics. This team of advisors leverages their extensive knowledge in oncology, ophthalmology, and inflammatory diseases to ensure the scientific robustness and innovation of Ashvattha’s therapeutic programs.

Scientific Advisory Team

Scientific Teams

Leadership Team

Scientific Advisory Team

About

Team members

Other teams at Ashvattha Therapeutics

Scientific Teams

Leadership Team